Estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2), are the tumor markers that have been widely studied in relation to the etiology, prognosis and treatment of breast cancer subtypes[8,38,39]. This evidence concerns the gene ERBB2 and neoplasm.